Nagoya, Japan

Tetsuya Segami

This inventor holds 2 USPTO granted patents. Top assignee: Arax Co., Ltd.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tetsuya Segami. Retrieved from https://idiyas.com/inventor/tetsuya-segami

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tetsuya Segami: Innovator in Imidazoline Derivatives

Introduction

Tetsuya Segami is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of chemistry, particularly in the development of imidazoline derivatives. With a total of 2 patents to his name, Segami's work is recognized for its potential applications in pharmaceuticals.

Latest Patents

Segami's latest patents include an imidazoline derivative and its possible tautomer, which is represented by a complex chemical formula. This invention focuses on the structural variations of imidazoline compounds, which may have various applications in medicinal chemistry. Another patent involves an imidazole derivative, which also showcases intricate chemical structures and potential pharmaceutical uses.

Career Highlights

Throughout his career, Tetsuya Segami has been associated with Arax Co., Ltd., where he has contributed to innovative research and development. His work has been instrumental in advancing the understanding of imidazoline and imidazole derivatives, which are crucial in the pharmaceutical industry.

Collaborations

Segami has collaborated with notable colleagues, including Eitaro Arakawa and Tetsuo Kato. These partnerships have fostered a collaborative environment that enhances the research and development of new chemical compounds.

Conclusion

Tetsuya Segami's contributions to the field of chemistry, particularly through his patents on imidazoline derivatives, highlight his innovative spirit and dedication to advancing pharmaceutical science. His work continues to inspire future research in this vital area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…